Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Huston

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2020
A Veterinarian From Vermont Presenting With a Painful Right Index Finger Following a Needlestick Injury That Occurred While Caring for a DogPrateek Ghatage, Kristen K Pierce, Christina Wojewoda, et al.
Plos Pathogens|January 23, 2008
Entamoeba histolytica phagocytosis of human erythrocytes involves PATMK, a member of the transmembrane kinase familyDouglas R Boettner, Christopher D Huston, Alicia S Linford, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2018
Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have <i>In Vitro</i> Activity against CryptosporidiumLuther A Bartelt, David T Bolick, Glynis L Kolling, et al.
Parasitology International|May 22, 2026
Randomized clinical trial evaluating triazolopyridazine SLU-2633 as a treatment for gastric cryptosporidiosis in eastern indigo snakes (Drymarchon couperi)James E Bogan, Christopher D Huston, Marvin J Meyers, et al.
Bioorganic & Medicinal Chemistry|May 6, 2023
Structure-Activity relationships of replacements for the triazolopyridazine of Anti-Cryptosporidium lead SLU-2633Edmund Oboh, José E Teixeira, Tanner J Schubert, et al.
Plos Neglected Tropical Diseases|January 9, 2018
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis modelErin Stebbins, Rajiv S Jumani, Connor Klopfer, et al.
Journal of Medicinal Chemistry|December 23, 2024
Discovery of an Orally Efficacious Pyrazolo[3,4-<i>d</i>]pyrimidine Benzoxaborole as a Potent Inhibitor of <i>Cryptosporidium</i>Makafui Gasonoo, Soumitra Guin, José E Teixeira, et al.
Plos Neglected Tropical Diseases|February 4, 2017
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosisMelissa S Love, Federico C Beasley, Rajiv S Jumani, et al.
Bioorganic & Medicinal Chemistry|February 7, 2017
Discovery and structure activity relationship of the first potent cryptosporidium FIKK kinase inhibitorKhan T Osman, Juntao Ye, Zhihao Shi, et al.
Journal of Medicinal Chemistry|August 3, 2021
Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety MarginEdmund Oboh, Tanner J Schubert, Jose E Teixeira, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2020
A Veterinarian From Vermont Presenting With a Painful Right Index Finger Following a Needlestick Injury That Occurred While Caring for a DogPrateek Ghatage, Kristen K Pierce, Christina Wojewoda, et al.
Plos Pathogens|January 23, 2008
Entamoeba histolytica phagocytosis of human erythrocytes involves PATMK, a member of the transmembrane kinase familyDouglas R Boettner, Christopher D Huston, Alicia S Linford, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2018
Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have <i>In Vitro</i> Activity against CryptosporidiumLuther A Bartelt, David T Bolick, Glynis L Kolling, et al.
Parasitology International|May 22, 2026
Randomized clinical trial evaluating triazolopyridazine SLU-2633 as a treatment for gastric cryptosporidiosis in eastern indigo snakes (Drymarchon couperi)James E Bogan, Christopher D Huston, Marvin J Meyers, et al.
Bioorganic & Medicinal Chemistry|May 6, 2023
Structure-Activity relationships of replacements for the triazolopyridazine of Anti-Cryptosporidium lead SLU-2633Edmund Oboh, José E Teixeira, Tanner J Schubert, et al.
Plos Neglected Tropical Diseases|January 9, 2018
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis modelErin Stebbins, Rajiv S Jumani, Connor Klopfer, et al.
Journal of Medicinal Chemistry|December 23, 2024
Discovery of an Orally Efficacious Pyrazolo[3,4-<i>d</i>]pyrimidine Benzoxaborole as a Potent Inhibitor of <i>Cryptosporidium</i>Makafui Gasonoo, Soumitra Guin, José E Teixeira, et al.
Plos Neglected Tropical Diseases|February 4, 2017
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosisMelissa S Love, Federico C Beasley, Rajiv S Jumani, et al.
Bioorganic & Medicinal Chemistry|February 7, 2017
Discovery and structure activity relationship of the first potent cryptosporidium FIKK kinase inhibitorKhan T Osman, Juntao Ye, Zhihao Shi, et al.
Journal of Medicinal Chemistry|August 3, 2021
Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety MarginEdmund Oboh, Tanner J Schubert, Jose E Teixeira, et al.
Pageof 6